Emerging role of human epidermal growth factor 2-low status in the prognosis and management of triple-negative breast cancer: a narrative review

Nathan Oelschlagel, Hamid Mithoowani, Emily A. Goebel, Farhad Ghasemi, Sarah Knowles, Allison Maciver, Muriel Brackstone, Armen Parsyan

Open source

DOI: 10.21037/tcr-2026-1-0370
Published: 2026-07
Container: Translational Cancer Research
Publisher: AME Publishing Company
Open access: unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

supportingDOI registered: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
supportingDOI resolves: A matching record was returned by Crossref. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredOpen access status: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
supportingMetadata completeness: All 6 scored descriptive metadata groups are present. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.21037/tcr-2026-1-0370,
  title = {Emerging role of human epidermal growth factor 2-low status in the prognosis and management of triple-negative breast cancer: a narrative review},
  author = {Nathan Oelschlagel and Hamid Mithoowani and Emily A. Goebel and Farhad Ghasemi and Sarah Knowles and Allison Maciver and Muriel Brackstone and Armen Parsyan},
  year = {2026},
  journal = {Translational Cancer Research},
  doi = {10.21037/tcr-2026-1-0370},
  url = {https://doi.org/10.21037/tcr-2026-1-0370}
}

RIS

TY  - JOUR
TI  - Emerging role of human epidermal growth factor 2-low status in the prognosis and management of triple-negative breast cancer: a narrative review
AU  - Nathan Oelschlagel
AU  - Hamid Mithoowani
AU  - Emily A. Goebel
AU  - Farhad Ghasemi
AU  - Sarah Knowles
AU  - Allison Maciver
AU  - Muriel Brackstone
AU  - Armen Parsyan
PY  - 2026
JO  - Translational Cancer Research
DO  - 10.21037/tcr-2026-1-0370
UR  - https://doi.org/10.21037/tcr-2026-1-0370
ER  -

APA

Oelschlagel, N., Mithoowani, H., Goebel, E. A., Ghasemi, F., Knowles, S., Maciver, A., Brackstone, M., & Parsyan, A. (2026). Emerging role of human epidermal growth factor 2-low status in the prognosis and management of triple-negative breast cancer: a narrative review. Translational Cancer Research. https://doi.org/10.21037/tcr-2026-1-0370

Source records

crossref · retrieved 2026-11-05T06:20:59.215Z